Tags: Drug.

Silodosin (trade names Rapaflo (USA) Silodyx (Europe and South Africa) Rapilif (India) Silodal (India) Urief (Japan) Urorec (Russia)) is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate).

Silodosin.png
ATC prefix
G04
ATC suffix
CA04
Bioavailability
32.0
CAS number
160970-54-7
FDA UNII code
CUZ39LUY82
IUPAC name
1-(3-hydroxypropyl)-5-[(2R)-(2-[2-[2-(222-trifluoroethoxy)phenoxy]ethylamino)propyl]indoline-7-carboxamide
PubChem
5312125

Loading...

This page contains content from the copyrighted Wikipedia article "Silodosin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.